-

Eurofins Scientific SE: Weekly Report on Share Repurchases From 25th May to 29th May 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins Scientific SE (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

25/05/2026

FR0014000MR3

25 000

62.9108

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

25/05/2026

FR0014000MR3

5 000

63.1452

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

26/05/2026

FR0014000MR3

25 000

62.6524

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

26/05/2026

FR0014000MR3

5 000

62.6112

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

27/05/2026

FR0014000MR3

30 000

62.5550

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

27/05/2026

FR0014000MR3

10 000

62.5456

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

28/05/2026

FR0014000MR3

30 000

61.4394

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

28/05/2026

FR0014000MR3

10 000

61.4617

CEUX

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

29/05/2026

FR0014000MR3

30 000

62.3213

XPAR

EUROFINS SCIENTIFIC

529900JEHFM47DYY3S57

29/05/2026

FR0014000MR3

10 000

62.3032

CEUX

TOTAL

180 000

62.3358

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins Scientific SE

Eurofins

BOURSE:ERF
Release Versions
English

Contacts

Eurofins Scientific SE

More News From Eurofins

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Financial highlights in H1 2026 Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives. Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07/2026 FR0014000MR3 15 000 69.1984 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07...

Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, has reached an agreement with Element Materials Technology (“Element”) to acquire its Life Sciences Testing Services business in North America, for an enterprise value of $400m. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in Q4 2026. Element’s North America Life Sciences Testing Services inc...
Back to Newsroom